Back to Search
ERIC YUE, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1972972032Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
52607(TX)
Research & Publications (19)
Synthesis, structure-activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists.
PMID 19552437·J Med Chem·2009
7-preclinical
In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists.
PMID 19552436·J Med Chem·2009
7-preclinical
Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.
PMID 19507862·J Med Chem·2009
7-preclinical
Hip resurfacing arthroplasty: risk factors for failure over 25 years.
PMID 18813892·Clin Orthop Relat Res·2009
8-other
Impaction grafting using a cemented porous-coated modular acetabular component.
PMID 18358391·J Arthroplasty·2008
5-case
Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines.
PMID 18037290·Bioorg Med Chem Lett·2008
8-other
Structural insights into the design of nonpeptidic isothiazolidinone-containing inhibitors of protein-tyrosine phosphatase 1B.
PMID 17028182·J Biol Chem·2006
8-other
Structural basis for inhibition of protein-tyrosine phosphatase 1B by isothiazolidinone heterocyclic phosphonate mimetics.
PMID 16916797·J Biol Chem·2006
8-other
Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic.
PMID 16789735·J Med Chem·2006
8-other
Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: synthesis and structure-activity relationships of a peptide scaffold.
PMID 16769216·Bioorg Med Chem·2006
8-other
Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics.
PMID 16220970·J Med Chem·2005
8-other
Matrix metalloproteinase-activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity.
PMID 15897239·Mol Cancer Ther·2005
7-preclinical
Opposing effects of D1 and D2 receptor activation on odor discrimination learning.
PMID 14979796·Behav Neurosci·2004
4-observational
Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. Part 4: Heterocycles at C3.
PMID 14698155·Bioorg Med Chem Lett·2004
8-other
In vivo Doppler optical coherence tomography of mucocutaneous telangiectases in hereditary hemorrhagic telangiectasia.
PMID 14520301·Gastrointest Endosc·2003
8-other
Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 3. Structure activity relationships at C3(1,2).
PMID 12431051·J Med Chem·2002
8-other
Perceptual correlates of neural representations evoked by odorant enantiomers.
PMID 11739591·J Neurosci·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2400 AVENUE I
HUNTSVILLE, TX 77340 - Phone
- (936) 437-5497
Quick Facts
- NPI
- 1972972032
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile